Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico Patent applications |
Patent application number | Title | Published |
20160069911 | NON INVASIVE METHOD FOR PRENATAL DIAGNOSIS - The invention pertains to a method which allows separation of nucleated fetal cells, particularly fetal erythroblasts, from maternal peripheral blood. More specifically the invention relates to a non-invasive method which can isolate and provide intact nucleated fetal cells, and is useful for subsequent chromosome, gene expression and protein investigations, and is feasible at ail gestational ages. | 03-10-2016 |
20150320887 | METHOD FOR DIAGNOSING GLUTEN SENSITIVITY AND USES THEREOF - The present invention relates to a method for determining gluten sensitivity which uses a kit comprising: a kit identification code, at least one oral formulation of gluten and at least one oral formulation of placebo, each identified by a code, for random double-blind administration. The method provides for at least one step of taking said at least one oral formulation of gluten and said at least one oral formulation of placebo according to a double-blind protocol; and at least one step of collecting data relating to the heath status of said subject. | 11-12-2015 |
20130217123 | METHOD FOR DENTAL PULP CRYOPRESERVATION - The present invention relates to a method for cryopreserving the pulp of a non-exfoliated deciduous tooth, comprising a step of making with a laser a hole into the tooth removed from its physiological seat on the tooth neck. After making the hole, the tooth is contacted with a cryopreserving agent and then cryofrozen. An object of the invention further consists in mesenchymal stem cells isolated from the pulp of a cryopreserved tooth according to the method of the invention. | 08-22-2013 |
20120022155 | USE OF AMINAPHTONE FOR THE PREPARATION OF A MEDICAMENT FOR TREATING ARTERIOPATHIES - The subject of the present invention is the use of aminaphtone for the preparation of a medicament for treating arteriophaties, in particular arteriophaties of a degenerative inflammatory type. Preferably, said medicament is formulated for oral administration | 01-26-2012 |
20100189700 | CULTURE FOR EXPANDING STEM CELLS EX-VIVO - The present invention relates to a culture including a growth medium and a combination of cytokines consisting of i) interleukin-6 (IL6); ii) flt3-ligand (FLT3); iii) stem cell factor (SCF) and iv) thrombopoi-etin (TPO); the use of the culture for expanding. ex vivo stem cells and/or parental cells and cells differentiated therefrom, and the use of said cells obtainable from said expansion. | 07-29-2010 |